Ocugen (OCGN) Revenue & Revenue Breakdown
Ocugen Revenue Highlights
Latest Revenue (Y)
$4.05M
Latest Revenue (Q)
$1.37M
Ocugen Revenue by Period
Ocugen Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $4.05M | -32.82% |
| 2023-12-31 | $6.04M | 142.60% |
| 2022-12-31 | $2.49M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $42.62K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $8.00K | -69.23% |
| 2012-12-31 | $26.00K | - |
Ocugen generated $4.05M in revenue during NA 2024, up -32.82% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Ocugen Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $1.37M | -7.29% |
| 2025-03-31 | $1.48M | 93.85% |
| 2024-12-31 | $764.00K | -32.75% |
| 2024-09-30 | $1.14M | -0.44% |
| 2024-06-30 | $1.14M | 12.52% |
| 2024-03-31 | $1.01M | -83.20% |
| 2023-12-31 | $6.04M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | -100.00% |
| 2023-03-31 | $443.00K | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $42.58M | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2020-06-30 | $42.62K | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | -100.00% |
| 2013-09-30 | $3.00K | - |
Ocugen generated $1.37M in revenue during Q2 2025, up -7.29% compared to the previous quarter, and up 135.40% compared to the same period a year ago.
Ocugen Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ARCT | Arcturus Therapeutics | $152.31M | $28.30M |
| PRTA | Prothena | $135.16M | $4.42M |
| GOSS | Gossamer Bio | $114.70M | $11.49M |
| BCYC | Bicycle Therapeutics | $35.27M | $9.98M |
| LXRX | Lexicon Pharmaceuticals | $31.08M | $28.87M |
| IMAB | I-Mab | $27.64M | $1.10M |
| OCGN | Ocugen | $4.05M | $1.37M |
| QSI | Quantum-Si | $3.06M | $591.00K |
| CRVS | Corvus Pharmaceuticals | - | - |
| SLDB | Solid Biosciences | - | - |
| NGNE | Neurogene | - | - |